|
February 10, 2006
2006 Project Goals
My first visit to TRI (February 3 – 6) is now in the books, and I wanted to take a few minutes here to update the community on the activities from this weekend. We were able to accomplish a great deal of knowledge transfer from Charles and Wolfgang to myself, which will be very important as we move forward. Of more immediate concern to the science and community of the project, we established a strong set of goals for the coming year that will help to revitalize the project and give us a firm foundation for future improvements.
First and foremost, this project is about finding drugs that can help fight diseases. You all have done a lot of work over the last few years in crunching the candidates and targets that we have given you, and your efforts have whittled the field down to several top conformers. While we need to keep working on the current libraries and targets in order to find all of the promising conformers that we can, we realize that a large percentage of the solution space has already been visited. It is for this reason that our top priority for this quarter is the release of a new target and new candidate libraries. To that end, we have identified a promising Avian Flu target and two large libraries of commercially-available drug candidates. I am currently working on formatting the associated files for use with our software.
While the science of drug discovery is the central focus of the project, contributor statistics provide tangible, up-to-date metrics for users to gauge their activity and the contributions they have made to the search for drug treatments. To make tracking our progress a better, more meaningful experience for you (and us!), we are planning to update the statistics processing code to improve both accuracy and currency. I am working with Sengent to make sure we have access to a stable, up-to-date code base before I begin my development work.
Finally, this transition period in the project’s life cycle provides a good opportunity to step back and look at where we’ve been and where we would like to go in the future. Fairly soon, I will be releasing Vision and Values statements for the project, which will help guide our actions moving forward. These will be living documents, and I encourage you to participate in shaping the project by giving me your thoughts on these topics. Then, later in the year, we plan to publish a review article detailing D2OL’s accomplishments and our place in the historical and current Distributed Computing landscape for computational chemistry. This will serve as the perfect celebratory capstone on the first phase of the project as we turn the page and move forward.
As you can see, we had a busy weekend, and there is a lot of work to do in the coming year. I’m confident, though, that we’ll be able to make important improvements to the project and continue to do good science, and I look forward to working with the talented people at TRI and all of you in our dedicated user communities. Please don’t hesitate to contact me with any questions or concerns.
2006年2月10日
2006计划目标
我的对TRI的第一次访问已经提上日程(2月3-6日),我想在论坛这里花几分钟说一下下星期的活动安排。我们能够完成从Charles、Wolfgang到我的交接,这对以后的发展很重要。对科学和论坛比较关心的几个方面,我们确立了一套今年的工作目标,这将会帮助为项目恢复生气,并给我们今年的发展奠定一个坚实的基础。
首先,这是一个寻找能帮助对抗疾病的药物的项目。在过去的几年中大家已经计算了很多我们给你的目标和候选药物,而且你们的努力已经成功筛选出了一些最好的分子。然而我们现在仍然需要在现有的数据库和目标上继续努力,以找到所有可能的最佳药物分子,我们已经完成了大部分的计算任务。因此,这个季度我们的首要任务是发布新的目标和新的候选药物库。到目前为止,我们已经确认了一个禽流感目标和二个大的商业药物数据库-可用的候选药物。我现在正在将它们格式化为我们的软件能用的文件。
药物寻找科学是项目关注的焦点,贡献者的统计资料为贡献者们搜寻治疗药物的过程,提供翔实的、最新的统计数据。为了更好的记录我们的过程,对你们(和我们!)都有好处,我们正在计划更新处理程序,改善准确性和统计速度。我正在与Sengent合作确保,在我开始我的开发工作之前,我们有一个稳定、且最新的数据库。
最后, 项目的这次转变给我们提供一个很好的回首过去、展望未来的机会。很快,我将会发布项目的目标和功能说明,这将会我们未来的行动指明方向。它们将会以在线文档的形式发布,而且我鼓励你参我们的项目计划,积极发表您的看法。然后,在年末,我们计划出版一篇回顾文章,详细描述D2OL的成就,和在计算化学领域所作的贡献。这将会为项目的第一阶段画上一个圆满的句号。
如您所见,我们周末很忙,而且今年还有许多工作要做。我有信心,我们的项目将会有重大进步,而且继续做好科学研究,我盼望与我们论坛的热衷参与者,及TRI的天才同事们合作。如果有任何的疑问,不要犹豫,请立即联系我。
[ Last edited by vmzy on 2006-4-17 at 14:34 ]
|